Hemofiltration with the cascade system in an experimental porcine model of septic shock

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 1, 2009, Pages 63-70

  Rimmelé, Thomas ^a   Wey, Pierre François ^a   Bernard, Nicolas ^a   Monchi, Mehran ^b   Semenzato, Nicolas ^a   Benatir, Farida ^a   Boselli, Emmanuel ^a   Etienne, Jérôme ^a,c   Goudable, Joëlle ^a,d   Chassard, Dominique ^a   Bricca, Giampiero ^a   Allaouchiche, Bernard ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Institut Jacques Cartier   (France)

Author keywords

Animal model; Cascade hemofiltration; Cytokine; High volume hemofiltration; Septic shock

Indexed keywords

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PH; COLLOID; DISEASE SEVERITY; EXPERIMENTAL PIG; EXTRACORPOREAL CIRCULATION; FEMALE; HEMOFILTRATION; INTERMETHOD COMPARISON; LACTIC ACIDOSIS; LUNG ARTERY PRESSURE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAFILTRATION;

ACIDOSIS, LACTIC; ADRENERGIC AGONISTS; ANIMALS; BLOOD PRESSURE; COLLOIDS; DISEASE MODELS, ANIMAL; EPINEPHRINE; FEMALE; HEMOFILTRATION; INFLAMMATION MEDIATORS; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SWINE;

EID: 62149083295     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00655.x     Document Type: Article

References (41)

1. Bellomo R, Honore PM, Matson J, Ronco C, Winchester J. Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Int J Artif Organs 2005 28 : 450 8.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001 29 : 1303 10.
3. Alberti C, Brun-Buisson C, Burchardi H et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002 28 : 108 21.
4. Brun-Buisson C, Doyon F, Carlet J et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995 274 : 968 74.
5. Crowther MA, Marshall JC. Continuing challenges of sepsis research. JAMA 2001 286 : 1894 6.
6. Dellinger RP, Carlet JM, Masur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004 32 : 858 73.
7. Bellomo R, Ronco C. Blood purification in the intensive care unit: evolving concepts. World J Surg 2001 25 : 677 83.
8. Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhe P, Safran D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. Anesthesiology 1994 81 : 1181 9 discussion A1126 7.
9. Kellum JA, Venkataraman R. Application of blood purification to non-renal organ failure. Int J Artif Organs 2005 28 : 445 9.
10. Tetta C, D'Intini V, Bellomo R et al. Extracorporeal treatments in sepsis: are there new perspectives? Clin Nephrol 2003 60 : 299 304.
11. Ronco C, Tetta C, Mariano F et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003 27 : 792 801.
12. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000 161 : 1429 36.
13. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001 27 : 978 86.
14. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992 18 : 235 40.
15. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004 50 : 102 9.
16. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 1999 25 : 814 21.
17. Ratanarat R, Brendolan A, Ricci Z et al. Pulse high-volume hemofiltration in critically ill patients: a new approach for patients with septic shock. Semin Dial 2006 19 : 69 74.
18. Allaouchiche B, Duflo F, Tournadre JP, Debon R, Chassard D. Influence of sepsis on sevoflurane minimum alveolar concentration in a porcine model. Br J Anaesth 2001 86 : 832 6.
19. Han JJ, Windsor A, Drenning DH et al. Release of endothelin in relation to tumor necrosis factor-alpha in porcine Pseudomonas aeruginosa-induced septic shock. Shock 1994 1 : 343 6.
20. Rimmele T, Assadi A, Benatir F et al. Validation of a Pseudomonas aeruginosa porcine model of septic shock. J Infect 2006 53 : 199 205.
21. Ridings PC, Holloway S, Bloomfield GL et al. Protective role of synthetic sialylated oligosaccharide in sepsis-induced acute lung injury. J Appl Physiol 1997 82 : 644 51.
22. Murphey ED, Traber DL. Pretreatment with tumor necrosis factor-alpha attenuates arterial hypotension and mortality induced by endotoxin in pigs. Crit Care Med 2000 28 : 2015 21.
23. Gasche Y, Pascual M, Suter PM, Favre H, Chevrolet JC, Schifferli JA. Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant 1996 11 : 117 19.
24. Kellum JA, Bellomo R, Mehta R, Ronco C. Blood purification in non-renal critical illness. Blood Purif 2003 21 : 6 13.
25. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998 26 : 1995 2000.
26. Mariano F, Tetta C, Guida G, Triolo G, Camussi G. Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int 2001 60 : 1598 605.
27. Honore PM, Jamez J, Wauthier M et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000 28 : 3581 7.
28. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999 27 : 1848 55.
29. Yekebas EF, Eisenberger CF, Ohnesorge H et al. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001 29 : 1423 30.
30. Adib-Conquy M, Adrie C, Moine P et al. NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 2000 162 : 1877 83.
31. Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000 356 : 26 30.
32. Bellomo R, Tan HK, Bhonagiri S et al. High protein intake during continuous hemodiafiltration: impact on amino acids and nitrogen balance. Int J Artif Organs 2002 25 : 261 8.
33. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000 28 : 1161 5.
34. Morgera S, Haase M, Kuss T et al. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006 34 : 2099 104.
35. Cole L, Bellomo R, Hart G et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002 30 : 100 6.
36. Heering P, Morgera S, Schmitz FJ et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997 23 : 288 96.
37. Sander A, Armbruster W, Sander B, Daul AE, Lange R, Peters J. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 1997 23 : 878 84.
38. Morgera S, Klonower D, Rocktäschel J et al. TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients? Nephrol Dial Transplant 2003 18 : 1361 9.
39. Uchino S, Bellomo R, Goldsmith D et al. Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 2002 28 : 651 5.
40. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999 10 : 846 53.
41. Ronco C, Brendolan A, Lonnemann G et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002 30 : 1250 5.